Lb Pharmaceuticals (LBRX) Treasury Shares (2024 - 2026)

Lb Pharmaceuticals' Treasury Shares history runs 3 years deep, the most recent figure standing at $92000.0 for Q1 2026.

• On a quarterly basis, Treasury Shares fell 68.86% year-over-year to $92000.0 in Q1 2026; TTM through Mar 2026 was $92000.0, a 68.86% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 91.0% from the prior year.
• Treasury Shares declined to $92000.0 in Q1 2026 per LBRX's latest filing, from $6.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $73.8 million in Q4 2024 and bottomed at $92000.0 in Q1 2026.
• The 3-year median for Treasury Shares is $3.7 million (2024), against an average of $16.9 million.
• Across the five-year window, Treasury Shares slumped 91.0% in 2025 and tumbled 68.86% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $73.8 million in 2024, then slumped by 91.0% to $6.6 million in 2025, then slumped by 98.62% to $92000.0 in 2026.
• Per Business Quant, the three latest LBRX Treasury Shares figures stand at $92000.0 (Q1 2026), $6.6 million (Q4 2025), and $295467.0 (Q1 2025).